Commercial Excellence
16 posts analyzed over the last 12 weeks
Over the last 12 weeks
Average across all posts
This month vs. previous
Growth slope (6 weeks)
16 posts analyzed over the last 12 weeks
Over the last 12 weeks
Average across all posts
This month vs. previous
Growth slope (6 weeks)
Best week: 4 mai (13 avg. likes)
Lounas A.
CCO 🎯 - Transformation & Commercial excellence 📈 - International (Paris-Amsterdam-Europe) 🌍 - Passionate street photographer 📸
“We’re far from target. I want a touchpoint every day at 8:30, your forecast, what you’ve closed, why we’re not getting there and your plan.” I’ve lived this. I suspect many of you have too. The first thing that happen…
Lounas A.
CCO 🎯 - Transformation & Commercial excellence 📈 - International (Paris-Amsterdam-Europe) 🌍 - Passionate street photographer 📸
Fully agree with Esther Andersen when she says: “Half the people trust the numbers. The other half don’t.” Indeed, KPIs should measure what truly matters. A question though: 👉 You KPIs might look impressive, but are t…
Lounas A.
CCO 🎯 - Transformation & Commercial excellence 📈 - International (Paris-Amsterdam-Europe) 🌍 - Passionate street photographer 📸
« On est loin des objectifs. Je veux un point tous les jours à 8h30, votre forecast, ce que vous avez signé, pourquoi on n’y arrive pas et votre plan pour y arriver. » J’ai vécu cette situation. Et je pense que beaucoup…
Abdulla Basha
VP Marketing | GTM and Revenue Leadership | B2B SaaS | AI Platforms | 6sense | HubSpot | Salesforce | Full-Funnel Demand Generation | ABM | SaaS Marketing Leader of the Year 2023
The average pharma brand team burns over 9,000 hours a year on slide creation. Not strategy. Not insights. Slide creation. That number lands differently when you consider what those same teams pay agencies — often $300K…
Abdulla Basha
VP Marketing | GTM and Revenue Leadership | B2B SaaS | AI Platforms | 6sense | HubSpot | Salesforce | Full-Funnel Demand Generation | ABM | SaaS Marketing Leader of the Year 2023
73% of pharma marketers say their decks get rebuilt at least three times before a single MLR submission. Three times. For one deck. That stat came up in a roundtable I sat in on last month with commercial leads from si…
Abdulla Basha
VP Marketing | GTM and Revenue Leadership | B2B SaaS | AI Platforms | 6sense | HubSpot | Salesforce | Full-Funnel Demand Generation | ABM | SaaS Marketing Leader of the Year 2023
$180 million for a priority review voucher. That's what Rocket just sold theirs for. Pharma will pay nine figures to compress time. But ask the same companies to invest in compressing the time it takes to communicate a …
Abdulla Basha
VP Marketing | GTM and Revenue Leadership | B2B SaaS | AI Platforms | 6sense | HubSpot | Salesforce | Full-Funnel Demand Generation | ABM | SaaS Marketing Leader of the Year 2023
Most pharma launch decks don't fail because of bad slides. They fail because of bad decisions made six weeks before anyone opened PowerPoint. Hot take: the "deck problem" in pharma is almost never a deck problem. Watch…
Abdulla Basha
VP Marketing | GTM and Revenue Leadership | B2B SaaS | AI Platforms | 6sense | HubSpot | Salesforce | Full-Funnel Demand Generation | ABM | SaaS Marketing Leader of the Year 2023
11:47pm. The CMO was staring at 47 AI-generated slides that said absolutely nothing. Board meeting in 10 hours. A commercial leadership team I spoke with recently shared this story (anonymized, of course). They're at a…
Abdulla Basha
VP Marketing | GTM and Revenue Leadership | B2B SaaS | AI Platforms | 6sense | HubSpot | Salesforce | Full-Funnel Demand Generation | ABM | SaaS Marketing Leader of the Year 2023
$10M in drug ad spend buys you reach. It doesn't buy you the right deck for next Tuesday's medical affairs review. That gap — between big-budget brand work and the daily communication grind — is where most life sciences…
Abdulla Basha
VP Marketing | GTM and Revenue Leadership | B2B SaaS | AI Platforms | 6sense | HubSpot | Salesforce | Full-Funnel Demand Generation | ABM | SaaS Marketing Leader of the Year 2023
The FDA is now reviewing clinical trial data in real time from AstraZeneca and Amgen. Read that again. Real-time review. This isn't just a regulatory efficiency story. It's a communication story that most marketing lea…